Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02236663 · ClinicalTrials.gov registry record · NA

Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends

A NA study of Intimate Partner Violence, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
649
Enrollment target
4
Study locations

NCT02236663 is a NA study of Intimate Partner Violence that has completed, run by Johns Hopkins University. The registered enrollment target is 649 participants, above the 311-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (109% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02236663, a NA study of Intimate Partner Violence, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
649 participants
Enrollment target
4
Study locations

Study Summary

Intimate partner violence (IPV), including violence in dating relationships (dating violence, DV) is a widespread and serious public health problem. Among U.S. female IPV survivors, 47.1% report their first abusive relationship occurred at college age (age 18-24). Similarly, in national surveys, adults respondents 18-24 years of age report the highest rate of stalking victimization, most commonly by a former intimate partner. Safety planning is the most widely used intervention to prevent and respond to IPV, yet the vast majority of abused women never access safety planning services. Our challenge is to increase college women's access to safety planning, with the opportunity to consider their unique safety priorities and level of danger during and when ending an abusive relationship. In addition, while "bystander" interventions that train peers to safely intervene have been shown to be effective in sexual assault prevention on campus, and college women in abusive relationships most frequently disclose IPV to a friend, no similar interventions have been tested with friends for IPV response on campuses. Therefore, the objective of the study is to evaluate the: 1. effectiveness of an interactive, personalized smart phone and web based safety application ("App") intervention in Maryland and Oregon with: 1) college women (age 18-24) who experience IPV and 2) friends (age 18-24) of women experiencing IPV. The safety decision App allows the user to enter information on: a) relationship health; b) safety priorities; and c) severity of violence/danger in relationship. The App then uses the information to provide the user with a personalized safety planning information and resources; and 2. dissemination of the App nationally to determine the reach, adoption, implementation and maintenance of App use among university/college students.

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care Safety Planing App
  • BEHAVIORAL Personalized App-Based Safety Decision Aid

Study Locations (4)

Arizona

  • Arizona State University - Phoenix

Maryland

  • Johns Hopkins University School of Nursing - Baltimore

Missouri

  • University of Missouri - Columbia

Oregon

  • Kaiser Foundation Research Institute - Portland

Trial Details

FieldValue
Enrollment Target 649 participants
Start Date 2015-07
Est. Completion 2020-02-07
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT02236663

The ClinicalTrials.gov registry entry for NCT02236663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 649 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 311-participant average among 14 other Intimate Partner Violence trials with a reported enrollment target (109% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intimate Partner Violence appearing as the primary indexed condition, and to 2 interventions - of which Usual Care Safety Planing App is the first listed.

NCT02236663 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arizona, Maryland, Missouri.

Frequently Asked Questions

What is clinical trial NCT02236663 about?

NCT02236663 is a clinical study titled "Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends". Intimate partner violence (IPV), including violence in dating relationships (dating violence, DV) is a widespread and serious public health problem. Among U.S. female IPV survivors, 47.1% report their first abusive relationship occurred at college age (age 18-24). Similarly, in national surveys, adu...

What is the current status of trial NCT02236663?

This trial is currently completed. It is a NA study. The enrollment target is 649 participants. The study started on 2015-07. Estimated completion is 2020-02-07.

What conditions does trial NCT02236663 study?

This clinical trial studies the following conditions: Intimate Partner Violence.

What interventions are being tested in trial NCT02236663?

The interventions under investigation include: Usual Care Safety Planing App (BEHAVIORAL), Personalized App-Based Safety Decision Aid (BEHAVIORAL).

Who is sponsoring clinical trial NCT02236663?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02236663 being conducted?

This trial has 4 study locations across Arizona, Maryland, Missouri, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intimate Partner Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.